Table 1 Patients’ characteristics

From: The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial

Parameter

Number (%) or mean (s.d.)

Total number of patients enrolled

436

Age at first diagnosis (years)

66.9 (11.2)

Tumour stage

 FIGO Ia

69 (15.8)

 FIGO Ib

191 (43.8)

 FIGO Ic

67 (15.4)

 FIGO IIa

17 (3.9)

 FIGO IIb

23 (5.3)

 FIGO IIIa

29 (6.7)

 FIGO IIIb

4 (0.9)

 FIGO IIIc

24 (5.5)

 FIGO IVa

3 (0.7)

 FIGO IVb

9 (2.0)

Histological grade

 G1

190 (43.6)

 G2

151 (34.6)

 G3

95 (21.8)

Histological subtype

 Endometrioid histology

408 (93.6)

 Non-endometrioid histology (clear cell, serous carcinoma)

28 (6.4)

 Time of follow-up (months)

36.1 (31.1)

Recurrence status

 Number of patients with recurrent disease

76 (17.4)

 Time to recurrent disease (months)

19.9 (18.9)

Status at last observation

 Disease-free

340 (78.0)

 Stable disease

22 (5.0)

 Progressive disease

42 (9.6)

 Tumour-related death

20 (4.6)

 Death related to other causes

12 (2.8)

  1. Abbreviation: FIGO=International Federation of Gynecology and Obstetrics.